Walter and Leonore Annenberg Professor in Cardiology and Critical Care
Cardiology
Dr. Margaret M. Redfield, MD
|
|
Give Review
Margaret Redfield is an expert in the field of Cardiology. She studied medicine at Tulane University School of Medicine. She over the years received 3 awards: "Member", "Elected Member" and "Fellow (FACC)". Margaret M. Redfield, MD has written publications. She has 99 publications published with PubMed. The lastest paper is: 'Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Preclinical Diastolic Dysfunction (Stage B Heart Failure).' She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Preclinical Diastolic Dysfunction (Stage B Heart Failure).
- Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.
- Galectin-3 in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity i...
- Left atrial remodeling and function in advanced Heart failure with preserved or reduced ejection fraction.
- Nitrate's effect on activity tolerance in Heart failure with preserved ejection fraction trial: rationale and design.
- Myocardial Stiffness in Patients with Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin.
- A survey of clinician attitudes and self-reported practices regarding end-of-life care in Heart failure.
- Decongestion Strategies and Renin-Angiotensin-Aldosterone System Activation in Acute Heart Failure.
- Impact of Chronic changes in arterial compliance and resistance on left ventricular ageing in humans.
- Impact of General and Central Adiposity on Ventricular-Arterial Aging in Women and Men.
- Resting Ventricular-Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.
- GLP-1 Agonist Therapy for Advanced Heart Failure With Reduced Ejection Fraction: Design and Rationale for the Functional Impact of GLP-1 for Heart Failure Treatment St...
- Right Heart dysfunction in Heart failure with preserved ejection fraction.
- Dopamine vs nesiritide for acute Heart failure with renal dysfunction--reply.
- Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction.
- A Functional Genetic Variant (N521D) in Natriuretic Peptide Receptor 3 Is Associated with Diastolic Dysfunction: The Prevalence of Asymptomatic Ventricular Dysfunction...
- Optimized delivery system achieves enhanced endoMyocardial stem cell retention.
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial.
- Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular Disease in the general community: a 9-year follow-up study.
- Acute Heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy.
- Delayed intrinsicoid deflection onset in surface ECG lateral leads predicts left ventricular reverse remodeling after cardiac resynchronization therapy.
- Heart failure performance measures: eligibility and implementation in the community.
- Defining high-sensitivity cardiac troponin concentrations in the community.
- Depression, healthcare utilization, and death in Heart failure: a community study.
- Frailty and Healthcare Utilization Among Patients With Heart Failure in the Community.
- Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in Heart failure with preserved ejection fraction: a randomized clinical trial.
- Deranged myofilament phosphorylation and function in experimental Heart failure with preserved ejection fraction.
- Cardiac output response to exercise in relation to metabolic demand in Heart failure with preserved ejection fraction.
- Ultrafiltration in decompensated Heart failure with cardiorenal syndrome.
- Novel protein therapeutics for systolic Heart failure: chronic subcutaneous B-type natriuretic Peptide.
- Longitudinal changes in ejection fraction in Heart failure patients with preserved and reduced ejection fraction.
- Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP.
- Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in Heart failure with preserved ejection fraction.
- Left ventricular discoordination index measured by speckle tracking strain rate imaging predicts reverse remodelling and survival after cardiac resynchronization therapy.
- Strategies to screen for stage B as a Heart failure prevention intervention.
- Pulmonary pressures and death in Heart failure a community study.
- Sildenafil and B-type natriuretic peptide Acutely phosphorylate titin and improve diastolic distensibility in vivo.
- Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading.
- Experimental Mild Renal Insufficiency Mediates Early Cardiac Apoptosis, Fibrosis and Diastolic Dysfunction: A Kidney - Cardiac Connection.
- Impaired natriuretic and renal endocrine response to Acute volume expansion in pre-clinical systolic and diastolic dysfunction.
- Atrial Fibrillation and Mortality in Heart Failure: A Community Study.
- Progression of left ventricular diastolic dysfunction and risk of Heart failure.
- A genetic variant of the Atrial natriuretic Peptide gene is associated with cardiometabolic protection in the general community.
- Influence of sex and hormone status on circulating natriuretic peptides.
- Variable phenotype in murine transverse Aortic constriction.
- Who has advanced Heart failure? Definition and epidemiology.
- Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the Community.
- Diastolic and systolic Heart failure are distinct phenotypes within the Heart failure spectrum.
- Diastolic relaxation and compliance reserve during dynamic exercise in Heart failure with preserved ejection fraction.
- The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays.
- Symptom improvement after upgrade from right ventricular apical to biventricular pacing: Role of right and left ventricular volumes assessed with single-photon emissio...
- Familial aggregation of left ventricular geometry and association with parental Heart failure: the Framingham Heart Study.
- B-type natriuretic peptide levels and continuous-flow left ventricular assist devices.
- Global cardiovascular reserve dysfunction in Heart failure with preserved ejection fraction.
- Dyssynchrony indices to predict response to cardiac resynchronization therapy: a comprehensive prospective single-center study.
- Exercise hemodynamics enhance diagnosis of early Heart failure with preserved ejection fraction.
- Regulation of circulating progenitor cells in left ventricular dysfunction.
- Aortic root remodeling over the adult life course: longitudinal data from the Framingham Heart Study.
- Mineralocorticoid accelerates transition to Heart failure with preserved ejection fraction via "nongenomic effects".
- The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B Heart failure subjects.
- Hospitalizations after Heart failure diagnosis a community perspective.
- Prognostic value of biomarkers in Heart failure: application of novel methods in the community.
- Contractility and ventricular systolic stiffening in hypertensive Heart disease insights into the pathogenesis of Heart failure with preserved ejection fraction.
- Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data.
- Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide.
- Diagnosis, assessment, and treatment of non-Pulmonary arterial hypertension Pulmonary hypertension.
- Age-associated increases in pulmonary Artery systolic pressure in the general population.
- Pulmonary hypertension in Heart failure with preserved ejection fraction: a community-based study.
- Protein kinase G modulates human Myocardial passive stiffness by phosphorylation of the titin springs.
- Abnormal cardiac structure and function in the metabolic Syndrome: a population-based study.
- Central obesity: association with left ventricular dysfunction and mortality in the community.
- Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly Hypertensive canines.
- Titin isoforms, extracellular matrix, and global chamber remodeling in experimental dilated Cardiomyopathy: functional implications and mechanistic insight.
- Tumor necrosis factor-alpha and mortality in Heart failure: a community study.
- Anemia and Heart failure: a community study.
- Death in Heart failure: a community perspective.
- Comparison of echocardiographic dyssynchrony assessment by tissue velocity and strain imaging in subjects with or without systolic dysfunction and with or without left...
- The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated Heart failure patients with renal dysfunction.
- Mineralocorticoid signaling in transition to Heart failure with normal ejection fraction.
- Nesiritide in acute decompensated Heart failure: current status and future perspectives.
- Acute decompensated Heart failure and the cardiorenal syndrome.
- Revisiting methods for assessing and comparing left ventricular diastolic stiffness: impact of relaxation, external forces, hypertrophy, and comparators.
- Impact of arterial load and loading sequence on left ventricular tissue velocities in humans.
- Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model.
- Response to cardiac resynchronization therapy predicts survival in Heart failure: a single-center experience.
- Mineralocorticoid escape by the kidney but not the Heart in experimental asymptomatic left ventricular dysfunction.
- Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans.
- Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide.
- Cardiac structure and ventricular-vascular function in persons with Heart failure and preserved ejection fraction from Olmsted County, Minnesota.
- Prevalence and prognostic significance of Heart failure stages: application of the American College of Cardiology/American Heart Association Heart failure staging crit...
- Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
- Impaired functional status and echocardiographic abnormalities signifying global dysfunction enhance the prognostic significance of previously unrecognized Myocardial ...
- Unexplained Pulmonary hypertension in elderly patients.
- BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors.
- Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory Heart failure: initial clinical experience in a single center.
- Systolic and diastolic Heart failure in the community.
- Membrane guanylyl cyclase receptors: an update.
- Trends in prevalence and outcome of Heart failure with preserved ejection fraction.
Schools
Tulane University School Of Medicine
Mayo Clinic Rochester
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Member
- Elected Member
- Fellow (FACC)
Education
-
Mayo School of Graduate Medical Education -
Tulane University School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1114999265 | |
| NPPES Provider LastName | REDFIELD | |
| NPPES Provider FirstName | MARGARET | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Cardiology | |
| Total Claim Count | 286.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114999265 |
| Last Name Of The Provider | REDFIELD |
| First Name Of The Provider | MARGARET |
| View All |
Similar Doctors
|
Dr. Jeffrey B. Geske, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric R. Fenstad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John F. Bresnahan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Horng H. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dawn C. Scantlebury, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy J. Thaden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marysia S. Tweet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Driscoll, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas J. Bunch, MD |
|
|
Dr. Steve R. Ommen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Natalie A. Bottega, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Iftikhar J. Kullo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gillian C. Nesbitt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barry L. Karon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Foley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Saurabh Sharma, MD |